The official blog of the Lung Institute.

Interstitial Lung Disease: What is ICD-10?

23 Sep 2016
| Under Interstitial Lung Disease, Lung Disease, Tips | Posted by | 0 Comments
Interstitial Lung Disease: What is ICD-10?

After an interstitial lung disease diagnosis, ICD codes can be confusing. We’re here to make sense of them.

What is ICD-10? In short, it’s an International Classification of Diseases (ICD) diagnosis code. These codes are used to properly note diseases on health records, track epidemiological trends and assist in medical reimbursement decisions. Put forth by the World Health Organization (WHO)—which develops and publishes these ICD codes—national governments and regulatory bodies have recently begun to adopt this system. Although stem cell therapy is not yet covered by current insurance options such as HMO’s, Medicare and Medicaid, it’s important to know just what ICD codes such as ICD-10 can mean for you, interstitial lung disease (ILD) and for your future treatment options.

With your health in mind, the Lung Institute is here to give the specifics of ICD codes and breakdown Interstitial Lung Disease: What is ICD-10?

What Is an ICD Code?

As we’ve previously mentioned, an ICD code is a code given by the WHO regarding new and emerging treatments. Split into two systems: ICD-10-CM (Clinical Modification) is used for diagnostic coding and ICD-10-PCS (Procedure Coding System) used for inpatient hospital procedure coding. Today, both systems comprise the newest and most expanded system of disease classification codes, delivering 68,000 codes with the ICD-10-CM edition compared to the previous ICD-9-CM which was only made up of 13,000 codes.

Interstitial Lung Disease: What is ICD-10?

How Does an ICD Code Affect my Interstitial Lung Disease?

To start, it is used to classify an interstitial lung disease diagnosis. This is significantly important to the process of communicating a diagnosis with other medical health providers in order to gain the best treatment recommendations. An ICD code also allows healthcare researchers to track disease trends, which may lead to deeper insights regarding the causes of the disease and which demographic may be most susceptible to it. On a more personal level, an ICD code can be used in conjunction with a CPT (Current Procedural Terminology) code in order to determine billing and medical reimbursements in treatment.

Improve My Quality of Life with Interstitial Lung Disease…

Although an interstitial lung disease prognosis can seem insurmountable, the first step to living a longer life is finding a treatment that addresses the disease head-on. Changing one’s diet and consistently exercising are among the best lifestyle changes one can do aside from quitting smoking. However, if you’re looking to address interstitial lung disease progression directly, it may be time to consider stem cell therapy. Rather than only addressing the symptoms of lung disease, stem cell therapy directly affects disease progression and can improve quality of life and pulmonary function. For people with lung disease, a change in quality of life could mean the difference between struggling to walk to the mailbox and riding a bike.

If you or a loved one suffers from a chronic disease like ILD, COPD, pulmonary fibrosis or other symptoms of lung disease, the Lung Institute may be able to help with a variety of adult stem cell treatment options. Contact us today at (800) 729-3065 to see if you qualify for stem cell therapy, and find out what stem cell therapy could mean for you.

Interested in our article on Interstitial Lung Disease: What is ICD-10? Share your thoughts and comments below.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.